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Background: Physical activity has emerged as an important lifestyle factor for primary 
prevention of numerous diseases, including postmenopausal breast cancer. No study to date has 
assessed the acute and long-term effects of year-long aerobic exercise programs differing in 
prescribed exercise volume on physical activity and sedentary time in postmenopausal women. 
Therefore, we aimed to examine the effects of two moderate-vigorous intensity exercise doses on 
total, light and moderate-vigorous intensity physical activity times, and sedentary time in 
postmenopausal women during the year-long intervention and one year later. Methods: The 
Breast Cancer and Exercise Trial in Alberta (BETA) was a two-center, two-arm, 12-month 
randomized controlled trial that included 400 previously inactive postmenopausal women 
randomized to either 150 (MODERATE) or 300 (HIGH) minutes/week of aerobic exercise. 
Physical activity and sedentary time were assessed at baseline, 6- (intervention mid-point), 12- 
(prior to end of intervention) and 24-months (follow-up) with waist-mounted accelerometers 
(Actigraph GTX3®). Self-reported activity and sedentary time at baseline, 12- and 24-months 
was also assessed (Past Year Total Physical Activity Questionnaire and SIT-Q). Intention-to-
treat analyses were conducted using linear mixed models and adjusted for baseline variables. 
Results: Both physical activity interventions led to increases in objective and subjective 
measures of total and moderate-vigorous intensity/recreational physical activity time, coupled 
with decreases in sedentary time, at 6- and 12-months compared to baseline. Additionally, 
greater increases in accelerometry-derived total physical activity time at 6- and 12-months, and 
self-reported recreational activity time at 12-months, compared to baseline were noted in the 
HIGH versus MODERATE groups. Decreases in total, light and moderate-vigorous intensity 
physical activity time, and an increase in sedentary time, in both groups were noted at 24-months 
compared to 12-months. A decrease in light intensity physical activity time in both groups at 24-
months compared to baseline was also noted. Conclusion: These findings have important health 
implications, suggesting that total physical activity time can be increased with greater volumes of 
prescribed exercise, but that additional support and resources could be used to promote the 
maintenance of these high levels of aerobic exercise participation following study completion. 
Trial registration: clinicaltrials.gov identifier: NCT01435005 (BETA Trial). Registred 
September 15th 2011 (retrospectively registered). 
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Abstract
Background: Physical activity has emerged as an important lifestyle factor for primary prevention of numerous
diseases, including postmenopausal breast cancer. No study to date has assessed the acute and long-term effects
of year-long aerobic exercise programs differing in prescribed exercise volume on physical activity and sedentary
time in postmenopausal women. Therefore, we aimed to examine the effects of two moderate-vigorous intensity
exercise doses on total, light and moderate-vigorous intensity physical activity times, and sedentary time in
postmenopausal women during the year-long intervention and one year later.
Methods: The Breast Cancer and Exercise Trial in Alberta (BETA) was a two-center, two-arm, 12-month randomized
controlled trial that included 400 previously inactive postmenopausal women randomized to either 150
(MODERATE) or 300 (HIGH) minutes/week of aerobic exercise. Physical activity and sedentary time were assessed at
baseline, 6- (intervention mid-point), 12- (prior to end of intervention) and 24-months (follow-up) with waist-
mounted accelerometers (Actigraph GTX3®). Self-reported activity and sedentary time at baseline, 12- and 24-
months was also assessed (Past Year Total Physical Activity Questionnaire and SIT-Q). Intention-to-treat analyses
were conducted using linear mixed models and adjusted for baseline variables.
Results: Both physical activity interventions led to increases in objective and subjective measures of total and
moderate-vigorous intensity/recreational physical activity time, coupled with decreases in sedentary time, at 6- and
12-months compared to baseline. Additionally, greater increases in accelerometry-derived total physical activity time
at 6- and 12-months, and self-reported recreational activity time at 12-months, compared to baseline were noted in
the HIGH versus MODERATE groups. Decreases in total, light and moderate-vigorous intensity physical activity time,
and an increase in sedentary time, in both groups were noted at 24-months compared to 12-months. A decrease in
light intensity physical activity time in both groups at 24-months compared to baseline was also noted.
Conclusion: These findings have important health implications, suggesting that total physical activity time can be
increased with greater volumes of prescribed exercise, but that additional support and resources could be used to
promote the maintenance of these high levels of aerobic exercise participation following study completion.
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Background
Physical activity has emerged as an important lifestyle
factor for primary prevention of numerous diseases in-
cluding but not limited to: cardiovascular disease [1, 2],
type 2 diabetes [3, 4] and certain types of cancers [5].
More recently, greater sedentary time has been identified
as a risk factor for developing obesity and other adverse
health outcomes [6, 7]. The menopausal transition in
particular is associated with weight and fat mass gains
[8, 9], which may partly result from decreased physical
activity time [10, 11], hence leaving postmenopausal
women at a heightened risk for developing adverse
health outcomes.
The Canadian Society for Exercise Physiology recom-
mends that adults should engage in at least 150 min of
moderate-vigorous intensity aerobic physical activity/
week to achieve health benefits [12]. However, findings
from a Canadian nationally representative sample com-
pleted in 2007–2009 with objective measurements of
physical activity time indicated that 85% of adults do not
meet these guidelines [13]. Furthermore, this report
noted a decline in total physical activity time coupled
with an increase in sedentary time with age [13]. There-
fore, the implementation of interventions and resources
promoting increases in total physical activity time and
lower sedentary time are needed, especially in older
adults.
A modest number of intervention studies have exam-
ined the effects of an exercise and/or diet intervention
on objectively-assessed physical activity time in post-
menopausal women [14–20]. It still remains uncertain
whether higher volumes of prescribed exercise
(300 min/week) would lead to greater increases in phys-
ical activity time and better maintenance of this increase
over the long term. Two studies have used pedometers
as an objective measurement of physical activity time
[19, 20]. The Women On the Move through Activity
and Nutrition (WOMAN) study found that pedometer
steps were significantly higher in the lifestyle interven-
tion compared to the health education group [19]. The
Dose Response to Exercise in Women (DREW) Trial
found a statistically significant linear trend between the
lowest and highest volume of exercise prescribed using
pedometer data [20]. Two more recent studies used ac-
celerometer devices [14, 18]. Specifically, The Diet, Exer-
cise, Metablism, and Obesity in Older Women (DEMO)
Trial randomized 36 postmenopausal women to caloric
restriction interventions combined with either a moder-
ate- or vigorous-intensity aerobic exercise component
[18]. This study found that participants had greater
physical activity time on days when they did not perform
center-based/supervised exercises, and that this differ-
ence was especially greater for participants randomized
to the vigorous-intensity aerobic exercise group. Add-
itionally, in the Sex Hormones and Physical Exercise
(SHAPE)-2 study, women randomized to the exercise
intervention were more physically active and less seden-
tary at follow-up (12-months post intervention) [14].
The Breast Cancer and Exercise Trial in Alberta
(BETA) assessed the dose-response effects of a year-long
prescribed aerobic exercise intervention on biomarkers
related to breast cancer risk in postmenopausal women
[21]. We collected objective measurements of physical
activity and sedentary time before, during and just prior
to the end of the intervention (baseline, 6- and 12-
months), as well as at follow-up (24-months). We also
collected self-reported, domain-specific measures of
physical activity and sedentary time at baseline, 12- and
24-months. The objective of the present analysis was to
examine the effects of prescribed aerobic exercise vol-




The design and methods for BETA are described in de-
tail elsewhere [21–23]. This two-center, two-arm ran-
domized controlled exercise intervention trial and
follow-up assessments were conducted in Calgary and
Edmonton (Alberta, Canada) between June 2010 and
June 2014. A total of 400 women were randomized to
the MODERATE (150 min of exercise/week) or HIGH
(300 min of exercise/week) volumes of aerobic exercise
interventions. Eligibility criteria included: age 50–
74 years, postmenopausal, no previous cancer diagnosis,
inactive (< 90 min/week of exercise or if between 90 and
120 min/week, a VO2peak < 34 ml/kg/min as measured
by a submaximal fitness test), a body mass index (BMI)
between 22 and 40 kg/m2, non-smoker, able to do unre-
stricted exercise as assessed by physician screening, and
not planning to undertake a weight loss or dietary pro-
gram. The study protocol was approved by the Alberta
Cancer Research Ethics Committee, the Conjoint Health
Research Ethics Board of the University of Calgary and
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the Health Research Ethics Board of the University of
Alberta. Informed consent was provided by all partici-
pants prior to study participation. This study followed
the CONSORT guidelines for reporting [24].
Exercise interventions
All participants were asked to exercise five days/week
accomplishing 65–75% of heart rate reserve for either
30 min (MODERATE) or 60 min (HIGH)/session. All
participants wore heart rate monitors to ensure that the
exercise was completed within the prescribed target
heart rate zones. Exercise sessions were supervised by
certified exercise trainers at fitness facilities in Calgary
and Edmonton on at least three days/week. Exercise on
the other two days/week could be unsupervised and
completed at a location of the participants choosing.
Participants could choose to exercise at the fitness facil-
ities on five days/week. Initially, exercise volume in-
creased gradually over a 12-week ramp-up period [21,
22, 25]. Exercise adherence was monitored with weekly
exercise logs completed by the exercise trainers. The ex-
ercise trainers also recorded information collected by
the heart rate monitors (exercise time, continuous heart
rate, time spent in the pre-determined heart rate zones
and the type of aerobic activities completed) during su-
pervised and unsupervised exercise sessions into a data-
base that was maintained at the recreational facilities in
Edmonton and Calgary during the year-long interven-
tion. Participants were aware that all outcome assess-
ments would be repeated at the 24-month time-point.
However, physical activity time was not monitored, nor
did participants receive an exercise prescription or had
access to the training facilities and exercise trainers dur-
ing the 12- to 24-month period.
Outcome measures
All outcomes were assessed at baseline, intervention mid-
point (6-months), just prior to the end of intervention (12-
months) and at follow-up (24-months). Total, moderate-
vigorous and light intensity physical activity times, and sed-
entary time were objectively-assessed with the ActiGraph®
GT3X+ device (ActiGraph LLC, Pensacola, Florida, USA).
Participants were asked to wear the activity monitor around
their waist during all waking hours (i.e. monitors were re-
moved during sleep), except for water-based activities, for
seven consecutive days at each time-point. A daily activity
monitor log was completed by each participant to record
the time when the accelerometer was worn and the types
of activities done during any “non-wear” time throughout
the day. Accelerometry data were collected from the Acti-
Graph® GT3X+ device at a sampling rate of 80 Hz and were
aggregated to 60-s epoch files for analysis by the ActiLife®
software (v6.10.2). For accelerometer data to be deemed
valid at each time-point, at least four days of 10 h of wear
time/day were needed. This amount of valid data was veri-
fied first with graphical displays computed by the ActiLife®
software and the participants’ daily activity monitor logs at
data collection and then through data processing. For cases
of invalid data at the collection phase, study staff asked par-
ticipants to wear the device for another seven consecutive
days. We used the Actigraph® Vertical Axis (VT) calcula-
tions [26, 27] to derive physical activity and sedentary time
outcomes from the accelerometry-measured activity
counts. First, total physical activity time (Metabolic Equiva-
lents of Task, METs) was calculated with the following re-
gression equation proposed by Freedson et al. [27]: METs/
min = 1.439008 + (0.000795 x vertical axis counts/min).
These values per minute were then summed and divided
by 60 to obtain total physical activity time values in MET-
hours/day. Second, the following cut-points were used to
define physical activity time according to intensity and sed-
entary time for the VT calculations: < 100 counts per mi-
nute (sedentary), 100–760 counts per minute (light
intensity) and > 760 counts per minute (moderate-vigorous
intensity). We applied the Choi algorithm to remove non-
wear time [28]. To account for potentially influential non-
wear time during activities captured in the activity monitor
logs filled out by participants, we first assigned a specific
MET value to the activity reported in the monitor logs ac-
cording to the values presented in the Compendium of
Physical Activities [29]. However, these values were not
compatible with the accelerometry-collected data. There-
fore, we attempted to apply a mean imputation value of
three METs for every hour of non-wear activity that was
documented [30], independently of the reported activity
that was performed during non-wear time. This mean im-
putation was only applied when an activity (e.g. cycling, jog-
ging) was reported by the participants in the activity logs
during non-wear time. No statistically significant differ-
ences were noted between mean imputed and non-imputed
total physical activity time (results not shown). Hence, we
decided not to include imputed non-wear activity values
into our estimates of physical activity time.
Self-reported activity and sedentary time were assessed
with the Past Year Total Physical Activity Questionnaire
(PYTPAQ) [31] and the SIT-Q [32] at baseline, 12- and 24-
months. These questionnaires assessed usual activity and sed-
entary time within the last 12 months. All activities reported
on the PYTPAQ were converted into MET-hours/week using
the Compendium of Physical Activities [29]. The derived
variables from the PYTPAQ included: total, occupational,
recreational, household and transportation activities. The
derived variables from the SIT-Q included: total, occupational
and leisure sedentary time, all reported as hours/day.
Statistical analyses
The sample size for BETA was based on the primary
endpoint of adiposity [22]. Sample size calculations
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estimated an initial sample size of 165 participants/
group at 12-months. We expected a < 15% loss at 24-
months, suggesting that at least 140 participants would
be included in the 24-month analyses [23]. For the
present analyses, it is estimated that the final sample
sizes of 140–170 participants per group with a pre-
determined power of 0.80 and a two-tailed α = 0.05 pro-
vided an effect size of Cohen’s d = 0.30–0.34 (small-
medium effect) to detect differences in total physical ac-
tivity and sedentary time outcomes between groups at 6-
, 12- and 24-months compared to baseline.
Differences in baseline participant characteristics be-
tween the MODERATE and HIGH groups were assessed
with a two-sample t-test for continuous variables or a χ2
test for categorical variables. An intention-to-treat ana-
lysis that included all participants with complete accel-
erometry data at baseline, 6-, 12- and/or 24-months
regardless of protocol adherence was used. This same
approach was used for the PYTPAQ and SIT-Q outcome
data at baseline, 12- and 24-months. Generalized linear
models estimated least-squares mean differences
(LSMD) in the change of physical activity and sedentary
time outcomes between the MODERATE and HIGH
groups for each time-point comparison. These models
were a priori adjusted for baseline values of age (years),
body mass index (BMI; kg/m2) and VO2peak (submaxi-
mal cardiorespiratory test; ml/kg/min), as well as differ-
ences in wear time (hours/day) between time-point
comparisons (for accelerometry data only). Full-time
employment status (work ≥ 35 h/week or < 35 h/week)
was also added as a covariate in the SIT-Q data analysis.
Potential effect modification for accelerometry-derived
total physical activity and sedentary time in the baseline
to 12 months and baseline to 24 months analyses were
assessed for the following variables based on their scien-
tific plausibility and support in previous research [33–
35]: age (years), marital status (married/common law or
other), study site (Calgary or Edmonton), education
(≤ high school or ≥ post-secondary school), ethnicity
(Caucasian or other), baseline VO2peak (ml/kg/min) and
baseline BMI (kg/m2). Since no evidence of effect modi-
fication was noted (results not shown), stratified analyses
were not conducted. Potential confounding was assessed
on the remaining variables not adjusted for a priori
using backwards elimination. All analyses were per-
formed using SAS (SAS 9.2 for Linux, SAS Institute
Inc.) [36]. Statistical significance was set at α < 0.05.
Results
The number of referred/invited and eligible participants,
as well as reasons for exclusion from randomization,
were previously reported [22]. Of the 400 participants
randomized at baseline, 331 and 283 participants had
complete and valid accelerometry data at baseline to 12-
months and baseline to 24-months, respectively (Fig. 1;
Study Flow Chart). A total of 321 and 272 participants
had complete and valid accelerometry data at baseline to
6-months and 12- to 24-months, respectively. Baseline
participant characteristics for those who had valid and
complete accelerometry data at baseline to 12-months
(n = 331) are presented in Table 1. There were no group
differences in accelerometer wear time at baseline (15.0
± 1.1 versus 15.1 ± 1.1 h/day; P = 0.7), 6-months (14.7 ±
1.1 versus 14.9 ± 1.1 h/day; P = 0.2), 12-months (14.9 ±
1.1 versus 14.9 ± 1.1 h/day; P = 0.6) and 24-months (14.9
± 1.1 versus 14.8 ± 1.1 h/day; P = 0.8).
Data on exercise adherence obtained from the exercise
logs maintained by the BETA Exercise Trainers are pre-
sented elsewhere [37–39]. There was no statistical differ-
ence in the number of completed supervised (2.2 ± 0.7
versus 2.1 ± 0.7 sessions/week; P = 0.4) and unsupervised
(1.6 ± 0.6 versus 1.5 ± 0.6 sessions/week; P = 0.8) sessions
between groups. For participants included in the accel-
erometry analyses, the HIGH group recorded greater ex-
ercise time during the intervention (two-sample t-test; P
< 0.0001), with 12-month median (quartiles 1, 3) adher-
ence values of 239 (193, 264) and 132 (115, 139) mi-
nutes/week. The median adherence rates for the HIGH
and MODERATE groups for weeks 13–52 (full exercise
prescription following the ramp-up period) were 262
(203, 292) and 140 (121, 150) minutes/week, respectively
(two-sample t-test; P < 0.0001).
Statistically significant increases in total and
moderate-vigorous intensity physical activity time, and a
decrease in sedentary time, were noted in both groups at
12-months compared to baseline (Table 2). Similar re-
sults were noted for changes in accelerometry-derived
outcomes between baseline and 6-months (Additional
file 1). However, only the increase in total physical activ-
ity time was greater in the HIGH versus MODERATE
group at 6-months, and borderline significant at 12-
months, compared to baseline. A statistically significant
increase in self-reported total and recreational activity
time, and a decrease in leisure sedentary time, were
noted in both groups at 12-months compared to base-
line (Additional file 2). This increase in self-reported
recreational activity time was also greater in the HIGH
vs. MODERATE group between these time points.
A statistically significant decrease in total, light and
moderate-vigorous intensity physical activity time, and
an increase in sedentary time, in both groups were noted
at 24-months compared to 12-months (Table 3). How-
ever, no differences in accelerometry-derived variables
were noted between groups between these time points.
A statistically significant decrease in self-reported total
and recreational activity were noted in both groups at
24-months compared to 12-months (Additional file 3).
Furthermore, this decrease in self-reported recreational
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Fig. 1 CONSORT diagram; the flow of participants through the BETA study, Alberta, Canada, 2010–2014. *Accelerometers were not given to
participants who had low adherence throughout the intervention or refused to wear the accelerometer a second time following invalid data (e.g.
device malfunction, did not wear the accelerometer for at least four days for 10 or more hours/day). **Participants who refused to wear the
accelerometer and/or wanted only to complete the study questionnaires at the 24-month time-point
Table 1 Baseline covariates for the participants randomized to the HIGH and MODERATE exercise groups in the Breast Cancer and
Exercise Trial in Alberta (BETA) (n = 331)
Characteristics HIGH group (300 min/week)
n = 170
MODERATE group (150 min/week)
n = 161
P-value
Age (years); mean ± SD 59 ± 5 59 ± 5 0.56
Baseline BMI (kg); mean ± SD 29 ± 4 29 ± 4 0.35
Baseline VO2peak (ml kg
− 1 min− 1); mean ± SD 27 ± 5 27 ± 5 0.97
Study site
Calgary; n (%) 125 (74) 120 (75) 0.84
Edmonton; n (%) 45 (26) 41 (25)
Marital status
Married or common law; n (%) 120 (71) 112 (70) 0.84
Other; n (%) 50 (29) 49 (30)
Education
≤ High school; n (%) 35 (21) 37 (23) 0.60
≥ Post-secondary school; n (%) 135 (79) 124 (77)
Ethnicity
Caucasian; n (%) 145 (85) 147 (91) 0.09
Other; n (%) 25 (15) 14 (9)
BMI Body mass index, SD Standard deviation, VO2peak Maximal oxygen uptake
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activity was greater in the HIGH versus MODERATE
group between these time points.
A statistically significant decrease in total physical activ-
ity time in the MODERATE group only and light intensity
activity time in both groups at 24-months compared to
baseline was observed (Table 4). No between-group differ-
ences in accelerometry-derived outcomes were noted be-
tween these time points. A statistically significant increase
in self-reported total and recreational activity, and a de-
crease in leisure sedentary time, in both groups at 24-
months compared to baseline was noted (Additional file
4). A decrease in self-reported total sedentary time at 24-
months compared to baseline was also noted in the HIGH
group only. There were no between-group differences in
self-reported activity and sedentary time measurements
between these time points.
Discussion
To our knowledge, this is the first study to assess the ef-
fects of different volumes of prescribed aerobic exercise
on total physical activity and sedentary time in postmen-
opausal women during a 12-month intervention and at
24-month follow-up. We noted increases in objective
and subjective measures of total and moderate-vigorous
intensity/recreational physical activity time, coupled with
decreases in sedentary time, in response to both volumes
of prescribed physical activity at 6- and 12-months.
These results are consistent with findings from a six-
week randomized controlled trial by Gomersall et al.
that prescribed 300 min/week versus 150 min/week of
aerobic physical activity versus no additional activity
(control) in previously inactive adults [40]. That study
reported statistically significant increases in total
Table 2 Changes in accelerometry-derived physical activity and sedentary time variables (baseline to 12-months) between HIGH and
MODERATE groups in BETA, Alberta, Canada, 2010–2014




LS Mean Change M (95% CI) P value b LS Group Difference M (95% CI) P value d
Total physical activity time (MET-h/d)
HIGH 25.2 (2.2) 26.3 (2.6) 1.03 (0.82, 1.23) < 0.001 0.29 (−0.0002, 0.59) 0.05
MODERATE 25.2 (2.1) 25.8 (2.4) 0.73 (0.52, 0.95) < 0.001
Total physical activity time (MET-h/wk)
HIGH 176.4 (15.4) 184.1 (18.2) 7.21 (5.74, 8.61) 2.03 (−0.014, 4.13)
MODERATE 176.4 (14.7) 180.6 (16.8) 5.11 (5.74, 8.61)
Moderate-vigorous physical activity time (h/d)
HIGH 2.0 (0.8) 2.3 (0.8) 0.34 (0.25, 0.44) < 0.001 0.12 (−0.03, 0.26) 0.11
MODERATE 2.0 (0.8) 2.2 (0.8) 0.23 (0.13, 0.33) < 0.001
Moderate-vigorous physical activity time (h/wk)
HIGH 14.0 (5.6) 16.1 (5.6) 2.38 (1.75, 3.08) 0.84 (− 0.21, 1.82)
MODERATE 14.0 (5.6) 15.4 (5.6) 1.61 (0.91, 2.31)
Light activity time (h/d)
HIGH 4.3 (1.0) 4.3 (0.9) 0.01 (− 0.09, 0.11) 0.88 0.01 (−0.13, 0.15) 0.94
MODERATE 4.2 (0.8) 4.2 (0.9) 0.002 (−0.10, 0.10) 0.97
Light activity time (h/wk)
HIGH 30.1 (7.0) 30.1 (6.3) 0.07(−0.63, 0.77) 0.07 (−0.91, 1.05)
MODERATE 29.4 (5.6) 29.4 (6.3) 0.01 (− 0.70, 0.70)
Sedentary time (h/d)
HIGH 8.7 (1.6) 8.3 (1.4) −0.48 (− 0.64, − 0.32) < 0.001 − 0.13 (− 0.36, 0.11) 0.28
MODERATE 8.9 (1.6) 8.5 (1.6) −0.35 (− 0.52, − 0.18) < 0.001
Sedentary time (h/wk)
HIGH 60.9 (11.2) 58.1 (9.8) −3.36 (−4.48, −2.24) −0.91 (−2.52, 0.77)
MODERATE 62.3 (11.2) 59.5 (11.2) −2.45 (− 3.64, −1.26)
CI Confidence interval, d Day, h Hours, LS Least-squares, M Mean, MET Metabolic equivalent of task, SD Standard deviation, wk Week
an = 170 and 161 for the HIGH and MODERATE groups, respectively
bP value for the test of significance for the null hypothesis that the LS mean difference across time equals 0
cLeast-square group mean of the High and Moderate exercise groups and their within- and between-group differences were estimated from general linear models
specified as: physical activity and sedentary time changes from baseline to 12-months = β0 + β1 (intervention group) + β2 (baseline outcome value) + β3 (age) + β4
(study site) + β5 (baseline BMI) + β6 (baseline VO2peak) + β7 (difference in accelerometer wear time between time-points)
dP value for the test of significance for the null hypothesis that the LS mean difference between the two intervention groups equals 0
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physical activity time in both exercise interventions
compared to control [40]. Additionally, our results con-
firmed that greater volumes of prescribed exercise led to
greater increases in total physical activity time at 6- and
12-months compared to baseline. The smaller difference
in total physical activity time change observed between
groups at 12- compared to 6-months (i.e. difference of
0.46 versus 0.29 MET-hours/day between groups at 6-
and 12-months) may be partly explained by slight differ-
ences in the completion rates of prescribed exercise ses-
sions following the ramp-up period between groups
(91% and 84% in the MODERATE and HIGH exercise
groups) and/or greater improvements in exercise econ-
omy/efficiency over time with higher training volumes
[41]. Data on self-reported activity that we obtained via
the PYTPAQ corroborate these findings, indicating that
recreational activity was significantly greater at 12-
months compared to baseline in the HIGH versus
MODERATE exercise groups. As previously reported
[22], mean reductions in total body fat, abdominal fat,
BMI, waist circumference and waist to hip ratio were
greater in the HIGH vs. MODERATE groups at 12-
months compared to baseline, with the greatest reduc-
tions in adiposity occurring in participants reporting
more than 250 min/week of exercise. It is therefore sug-
gested that greater volumes of aerobic exercise led to
greater decreases in adiposity measures in these
participants.
Decreases in total, light and moderate-vigorous inten-
sity physical activity time, and an increase in sedentary
time, in both groups were noted at 24-months compared
to 12-months. Additionally, decreases in self-reported
Table 3 Changes in accelerometry-derived physical activity and sedentary time variables (12- to 24-months) between HIGH and
MODERATE groups in BETA, Alberta, Canada, 2010–2014




LS Mean Change b
M (95% CI)
P value c LS Group Difference b
M (95% CI)
P value d
Total physical activity time (MET-h/d)
HIGH 26.5 (2.6) 25.2 (2.5) −1.29 (− 1.48, − 0.88) < .001 − 0.22 (− 0.49, 0.05) 0.11
MODERATE 26.2 (2.2) 25.1 (2.4) − 1.07 (− 1.26, − 0.88) < .001
Total physical activity time (MET-h/wk)
HIGH 185.5 (18.2) 176.4 (17.5) −9.03 (− 10.36, −6.16) −1.54 (−3.43, 0.35)
MODERATE 183.4 (15.4) 175.7 (16.8) −7.49 (−8.82, −6.16)
Moderate-vigorous physical activity time (h/d)
HIGH 2.3 (0.8) 1.9 (0.8) −0.41 (− 0.50, − 0.31) < .001 − 0.05 (− 0.18, 0.09) 0.50
MODERATE 2.2 (0.8) 1.9 (0.8) − 0.36 (− 0.46, − 0.26) < .001
Moderate-vigorous physical activity time (h/wk)
HIGH 16.1 (5.6) 13.3 (5.6) −2.87 (−3.50, − 2.17) − 0.35 (− 1.26, 0.63)
MODERATE 15.4 (5.6) 13.3 (5.6) −2.52 (−3.22, − 1.82)
Light activity time (h/d)
HIGH 4.4 (0.9) 4.2 (0.9) −0.17 (− 0.28, − 0.06) 0.002 0.02 (− 0.14, 0.17) 0.82
MODERATE 4.3 (0.9) 4.1 (0.9) −0.19 (− 0.30, − 0.08) < .001
Light activity time (h/wk)
HIGH 30.8 (6.3) 29.4 (6.3) −1.19 (− 1.96, − 0.42) 0.14 (− 0.98, 1.19)
MODERATE 30.1 (6.3) 28.7 (6.3) −1.33 (−2.10, − 0.56)
Sedentary time (h/d)
HIGH 8.3 (1.4) 8.8 (1.6) 0.44 (0.27, 0.60) < .001 0.04 (−0.19, 0.27) 0.75
MODERATE 8.5 (1.4) 8.9 (1.5) 0.40 (0.23, 0.56) < .001
Sedentary time (h/wk)
HIGH 58.1 (9.8) 61.6 (11.2) 3.08 (1.89, 4.20) 0.28 (−1.33, 1.89)
MODERATE 59.5 (9.8) 62.3 (10.5) 2.80 (1.61, 3.92)
CI Confidence interval, d Day, h Hours, LS Least-squares, M Mean, MET Metabolic equivalent of task, SD Standard deviation, wk Week
an = 138 and 134 for the HIGH and MODERATE groups, respectively
bLeast-square group mean of the High and Moderate exercise groups and their within- and between-group differences were estimated from general linear models
specified as: physical activity and sedentary time changes from 12- to 24-months = β0 + β1 (intervention group) + β2 (12-month outcome value) + β3 (age) + β4
(study site) + β5 (baseline BMI) + β6 (baseline VO2peak) + β7 (difference in wear time between time-points)
cP value for the test of significance for the null hypothesis that the LS mean difference across time equals 0
dP value for the test of significance for the null hypothesis that the LS mean difference between the two intervention groups equals 0
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total and recreational activity were observed in both
groups at 24-months compared to 12-months, with sig-
nificantly greater reductions in self-reported recreational
activity in the HIGH versus MODERATE groups at 24-
months compared to 12-months. A decrease in light in-
tensity physical activity time in both groups and a de-
crease in total physical activity time in the MODERATE
group only were also noted at 24-months compared to
baseline. Our recent paper examining the changes in
adiposity measurements in BETA at follow-up reported
increases in total body fat between 12 and 24 months in
both groups [23], which may be partially explained by
this decrease in total physical activity time following
study completion. Gomersall et al. [40] reported similar
findings, indicating that total physical activity time
returned to baseline levels in all groups (300 min/week
versus 150 min/week versus control) six months follow-
ing the end of the six-week intervention. Conversely,
other studies reported an increase in moderate-vigorous
intensity physical activity time and/or lower sedentary
time at follow-up versus baseline [14, 42]. A meta-
analysis indicated that the degree of energy compensa-
tion (i.e. amount of weight loss below what is expected
for the amount of exercise energy expenditure) is highly
variable for exercise interventions of short durations (<
20 weeks), but approaches 100% (i.e. no changes in body
weight, despite increased exercise participation) in exer-
cise interventions > 40 weeks in duration [43]. It is pos-
sible that delayed compensatory responses in total
physical activity time and/or sedentary time may be
greater in BETA as a result of the length of the interven-
tion and follow-up periods.
Table 4 Changes in accelerometry-derived physical activity and sedentary time variables (baseline to 24-months) between HIGH and
MODERATE groups in BETA, Alberta, Canada, 2010–2014




LS Mean Change b
M (95% CI)
P value c LS Group Difference b
M (95% CI)
P value d
Total physical activity time (MET-h/d)
HIGH 25.3 (2.2) 25.2 (2.5) −0.19 (− 0.40, 0.03) 0.09 0.04 (− 0.26, 0.35) 0.80
MODERATE 25.3 (2.2) 25.0 (2.4) −0.23 (− 0.44, − 0.01) 0.04
Total physical activity time (MET-h/wk)
HIGH 177.1 (15.4) 176.4 (17.5) −1.33 (−2.80, 0.21) 0.28 (−1.82, 2.45)
MODERATE 177.1 (15.4) 175.0 (16.8) −1.61 (−3.08, −0.07)
Moderate-vigorous physical activity time (h/d)
HIGH 1.9 (0.8) 1.9 (0.8) −0.05 (− 0.16, 0.06) 0.38 0.03 (− 0.13, 0.19) 0.72
MODERATE 1.9 (0.9) 1.9 (0.8) −0.08 (− 0.19, 0.03) 0.16
Moderate-vigorous physical activity time (h/wk)
HIGH 13.3 (5.6) 13.3 (5.6) −0.35 (−1.12, 0.42) 0.21 (−0.91, 1.33)
MODERATE 13.3 (6.3) 13.3 (5.6) −0.56 (−1.33, 0.21)
Light activity time (h/d)
HIGH 4.4 (1.0) 4.2 (0.9) −0.17 (−0.28, − 0.05) 0.004 −0.02 (− 0.18, 0.13) 0.78
MODERATE 4.3 (0.8) 4.1 (0.9) −0.14 (− 0.25, − 0.03) 0.01
Light activity time (h/wk)
HIGH 30.8 (7.0) 29.4 (6.3) −1.19 (−1.96, −0.35) −0.14 (− 1.26, 0.91)
MODERATE 30.1 (5.6) 28.7 (6.3) −0.98 (−1.75, − 0.21)
Sedentary time (h/d)
HIGH 8.8 (1.6) 8.8 (1.5) −0.07 (− 0.24, 0.10) 0.43 0.02 (− 0.27, 0.23) 0.88
MODERATE 9.0 (1.5) 8.8 (1.5) −0.05 (− 0.22, 0.12) 0.56
Sedentary time (h/wk)
HIGH 61.6 (11.2) 61.6 (10.5) −0.49 (−1.68, 0.70) 0.14 (− 1.89, 1.61)
MODERATE 63.0 (10.5) 61.6 (10.5) −0.35 (−1.54, 0.84)
CI Confidence interval, d Day, h Hours, LS Least-squares, M Mean, MET Metabolic equivalent of task, SD Standard deviation, wk Week
an = 140 and 143 for the HIGH and MODERATE groups, respectively
bLeast-square group mean of the High and Moderate exercise groups and their within- and between-group differences were estimated from general linear models
specified as: physical activity and sedentary time changes from baseline to 24-months = β0 + β1 (intervention group) + β2 (baseline outcome value) + β3 (age) + β4
(study site) + β5 (baseline BMI) + β6 (baseline VO2peak) + β7 (difference in wear time between time-points)
cP value for the test of significance for the null hypothesis that the LS mean difference across time equals 0
dP value for the test of significance for the null hypothesis that the LS mean difference between the two intervention groups equals 0
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It is very likely that decreases in total physical activity
time and/or increases in sedentary time are expected to
occur following the end of an exercise intervention (i.e.
the changes in our outcome measures reflect the re-
moval of the intervention rather than the maintenance
of an intervention), thus highlighting the challenges of
implementing these types of exercise interventions or
recommendations into the real world. Indeed, one study
speculated that it may be difficult for participants in a
structured exercise intervention group to find new ways/
settings to maintain their physical activity routine fol-
lowing study completion, compared to those randomized
to a home-based physical activity program [44]. Recent
studies have tried to implement strategies to prevent re-
versions in total physical activity time following the
completion of exercise interventions. More specifically, a
two-arm intervention by Niklas et al. [45] investigated
the effects of adding a self-monitoring intervention with
accelerometry to a traditional diet and exercise trial, ver-
sus diet and exercise alone, on total physical activity
time and anthropometrics during a five-month weight
maintenance period in older overweight adults. The au-
thors reported a positive trend towards greater light in-
tensity activity time in the group with the added self-
monitoring intervention compared to diet and exercise
alone. Cadmus-Bertram et al. [46, 47] also recently re-
ported an increase in moderate-vigorous intensity phys-
ical activity time following a 16-week self-monitoring
exercise intervention with a Fitbit® activity tracker in
postmenopausal women. Additionally, 96% of partici-
pants found the Fitbit® activity tracker to be “somewhat
or very helpful” for increasing total physical activity
time. Therefore, the addition of self-monitoring tools in
conjunction with a structured exercise program may
contribute to maintaining increased total physical activ-
ity and reduced sedentary time following study comple-
tion. Future studies evaluating the use of self-monitoring
tools to promote the maintainance of increased physical
activity and reduced sedentary time following an exercise
intervention are needed to corroborate the abovemen-
tioned findings.
Our results are mostly generalizable to healthy, post-
menopausal women. Strengths of BETA include the im-
plementation of a year-long exercise intervention
including supervised exercise sessions, a high adherence
rate in both exercise groups, a large sample size and the
inclusion of both objective and subjective assessments of
physical activity and sedentary time during the interven-
tion, at study completion and follow-up. Our limitations
include the large number of analyses conducted, which
may increase the chances of spurious findings. Addition-
ally, there were missing accelerometry data in all ana-
lyses. The most common reasons for missing
accelerometer data included refusal to wear the device
and lack of adherence to the trial, which may be evi-
dence of selection bias, since women who refused to
wear the devices may be more inactive than those who
did not. However, when comparing participants with
valid accelerometry data at baseline and 12-months (n =
331) versus participants without valid accelerometry data
(n = 69), age, BMI, VO2peak and measures of physical ac-
tivity and sedentary time did not differ between com-
pleters and non-completers, with the exception of light
intensity activity time (P = 0.01). Thus, the magnitude of
selection bias is minimal and may not influence our
overall results.
These findings suggest that total physical activity time
can be increased with greater volumes of prescribed ex-
ercise. However, physical activity and sedentary time
returned to baseline levels following study completion,
thus highlighting the challenges in implementing these
types of exercise interventions or recommendations into
the real world. Additional support and resources (e.g.
use of self-monitoring activity trackers) may be benefi-
cial to promote the maintenance of increased physical
activity and reduced sedentary time over the long-term
following study completion. Future studies should also
include qualitative and/or quantitative assessments of
common barriers to maintaining achieved increases in
physical activity participation and reduced sedentary
time following an exercise intervention.
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